These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32200677)

  • 21. Sodium alginate oligosaccharides attenuate hypertension and associated kidney damage in Dahl salt-sensitive rats fed a high-salt diet.
    Terakado S; Ueno M; Tamura Y; Toda N; Yoshinaga M; Otsuka K; Numabe A; Kawabata Y; Murota I; Sato N; Uehara Y
    Clin Exp Hypertens; 2012; 34(2):99-106. PubMed ID: 21967018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    Salah E; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):165-177. PubMed ID: 30839510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of P4504A activity improves pressure-natriuresis in Dahl S rats.
    Alonso-Galicia M; Frohlich B; Roman RJ
    Hypertension; 1998 Jan; 31(1 Pt 2):232-6. PubMed ID: 9453308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
    Kassab S; Miller MT; Novak J; Reckelhoff J; Clower B; Granger JP
    Hypertension; 1998 Jan; 31(1 Pt 2):397-402. PubMed ID: 9453335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal actions of atrial natriuretic peptide on the postischemic kidney.
    Akabane S; Imanishi M; Matsushima Y; Kawamura M; Kuramochi M; Ito K; Omae T
    Can J Physiol Pharmacol; 1988 May; 66(5):601-7. PubMed ID: 2970885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
    Mervaala E; Müller DN; Schmidt F; Park JK; Gross V; Bader M; Breu V; Ganten D; Haller H; Luft FC
    Hypertension; 2000 Feb; 35(2):587-94. PubMed ID: 10679502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats.
    Rahman A; Sawano T; Sen A; Hossain A; Jahan N; Kobara H; Masaki T; Kosaka S; Kitada K; Nakano D; Imamura T; Ohsaki H; Nishiyama A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
    Tian N; Gu JW; Jordan S; Rose RA; Hughson MD; Manning RD
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1018-25. PubMed ID: 17040973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
    Mendez RE; Dunn BR; Troy JL; Brenner BM
    Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic factor in sodium-sensitive and sodium-resistant Dahl rats.
    Sterzel RB; Luft FC; Gao Y; Lang RE; Ruskoaho H; Ganten D
    J Hypertens; 1987 Feb; 5(1):17-24. PubMed ID: 2953783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Liang B; Leenen FH
    J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure.
    Westermann D; Riad A; Richter U; Jäger S; Savvatis K; Schuchardt M; Bergmann N; Tölle M; Nagorsen D; Gotthardt M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2009 Sep; 104(5):499-509. PubMed ID: 19255799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
    Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.
    Shi YX; Chen Y; Zhu YZ; Huang GY; Moore PK; Huang SH; Yao T; Zhu YC
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2093-100. PubMed ID: 17630351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of elevation of ANP and its deficiency on cardiorenal function.
    Ilatovskaya DV; Levchenko V; Winsor K; Blass GR; Spires DR; Sarsenova E; Polina I; Zietara A; Paterson M; Kriegel AJ; Staruschenko A
    JCI Insight; 2022 May; 7(9):. PubMed ID: 35380994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide.
    Soejima H; Grekin RJ; Briggs JP; Schnermann J
    Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of atrial natriuretic factor on blood pressure, heart rate, and renal functions in conscious, spontaneously hypertensive rats.
    Gellai M; DeWolf RE; Kinter LB; Beeuwkes R
    Circ Res; 1986 Jul; 59(1):56-62. PubMed ID: 2942313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure.
    Shea CM; Price GM; Liu G; Sarno R; Buys ES; Currie MG; Masferrer JL
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F148-F159. PubMed ID: 31608671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.